Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2022-05-20

Clinical Trial Update: The Use of Fibrin Sealant to Reduce Post Operative Pain in Cleft Palate Surgery [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating fibrin sealant to reduce postoperative pain in cleft palate surgery has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fibrin sealant (fibrin sealant)

Snippet

Sponsor: University of Alberta | Conditions: Cleft Palate | Phase 4 | Status: WITHDRAWN